|
|
Partneringdesk: Deals and alliances in blood and diseasesPublished by: Pharmalicensing Ltd. Published: Jun. 1, 2005 - 342 Pages Table of ContentsIntroduction About Partneringdesk deals and alliances Blood and lymphatic diseases sector Chapter 1: Deals in blood and lymphatic diseases by company Chapter 2: Deals in blood and lymphatic diseases by development stage Chapter 3: Summary profiles for the most active companies in blood and lymphatic diseases Chapter 4: List of deals Glossary Pharmalicensing.com Partneringweek™ Partneringreview™ Other reports Order form Figures Fig. 1 Deal activity 2000-2005 Fig. 2 Deal activity last 12 months Fig. 3 Deal activity in blood and lymphatic diseases by year Fig. 4 Deal activity in blood and lymphatic diseases by type Fig. 5 Deal activity in blood and lymphatic diseases by development stage AbstractBlood disorders include sickle cell disease, hemophilia and other bleeding disorders, deep vein thrombosis, idiopathic thrombocytopenic purpura, pulmonary embolism, thalassemia, von Willebrand disease and others. In the USA in 2002, an estimated 251,000 deaths (10% percent of all deaths) were attributed to blood diseases, including 241,000 due to blood-clotting disorders and 10,000 due to diseases of the red blood cell and bleeding disorders. A large proportion of deaths from acute MI and cerebrovascular disease involve blood-clotting problemsGet Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||